Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 854.74M P/E - EPS this Y -1.40% Ern Qtrly Grth -
Income -56.54M Forward P/E -16.72 EPS next Y 10.30% 50D Avg Chg -23.00%
Sales 191.43M PEG -11.77 EPS past 5Y - 200D Avg Chg -48.00%
Dividend N/A Price/Book 5.50 EPS next 5Y 1.60% 52W High Chg -62.00%
Recommedations 3.30 Quick Ratio 6.28 Shares Outstanding 40.63M 52W Low Chg 12.00%
Insider Own 4.15% ROA -14.11% Shares Float 37.63M Beta 1.54
Inst Own 97.46% ROE -36.45% Shares Shorted/Prior 3.15M/2.57M Price 22.07
Gross Margin 74.28% Profit Margin -29.53% Avg. Volume 935,798 Target Price 20.75
Oper. Margin -33.56% Earnings Date Nov 6 Volume 1,457,113 Change -3.67%
About Silk Road Medical, Inc.

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. As of September 17, 2024, Silk Road Medical, Inc operates as a subsidiary of Boston Scientific Corporation.

Silk Road Medical, Inc. News
09/17/24 Acquisition News Lifted Silk Road Medical (SILK) in Q2
09/17/24 Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
09/13/24 Boston Scientific closes Silk Road Medical acquisition
09/12/24 Silk Road Medical (SILK) Surged After the Acquisition News
08/23/24 Here’s Why Silk Road Medical (SILK) was up 47.8% in Q2
08/20/24 Boston Scientific (BSX), Silk Road Merger Delayed for Review
08/16/24 Boston Scientific resubmits Silk Road merger filing, giving FTC more review time
08/12/24 The past three years for Silk Road Medical (NASDAQ:SILK) investors has not been profitable
08/07/24 Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates
08/07/24 Silk Road Medical: Q2 Earnings Snapshot
08/07/24 Silk Road Medical Reports Second Quarter 2024 Financial Results
07/30/24 Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/25/24 Q2 2024 Boston Scientific Corp Earnings Call
06/19/24 Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
06/19/24 Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn into More Strength?
06/18/24 Boston Scientific spends $1.26bn to acquire TCAR specialist Silk Road Medical
06/18/24 Silk Road Medical Shares Rally as Boston Scientific Plans Almost $1.2 Billion Acquisition
06/18/24 Boston Scientific Buys Silk Road Medical for $1.26 Billion
06/18/24 Boston Scientific buys Silk Road Medical for $1.26B
06/18/24 Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
SILK Chatroom

User Image LoyalShark Posted - 2 months ago

@GiveHerTheDD Take what we can get at this point. Piper was paid $1.5 million as part of the cap raise. They are not doing enough. The $4.50 is a discounted cash flow model they use is EXTREMELY conservative. Very safe. NSPR needs to knock on the door of all those tht follow $SILK and court them to follow them.

User Image Stock_Titan Posted - 2 months ago

$BSX $SILK Boston Scientific Closes Acquisition of Silk Road Medical, Inc. https://www.stocktitan.net/news/BSX/boston-scientific-closes-acquisition-of-silk-road-medical-ci9swgwsrerk.html

User Image tradethehalt Posted - 2 months ago

$SILK trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $27.49 Vol: 2.31M.

User Image NoFearHere Posted - 2 months ago

$SILK what a great opportunity this was when it started as an IPO missed this one but I've added it to the my watch list I looks like it might have hit the ceiling up here and could break down on watch though

User Image tradingcalendar Posted - 2 months ago

Silk Road Medical $SILK to be acquired by Boston Scientific $BSX - SILK shareholders to receive $27.50 cash per share - SILK stock to be delisted from Nasdaq after 8PM More Information : https://www.sec.gov/Archives/edgar/data/1397702/000114036124034482/ny20031663x2_defm14a.htm

User Image Mergerbrief Posted - 2 months ago

$SILK / $BSX - Shareholder Vote $SILK MergerBrief.com Sign Up For Full Schedule

User Image kinderspiel Posted - 3 months ago

$SKIN volume 2.5 m $CAN volume 2.4 m $BIRD volume 2.4 m $SILK volume 2.4 m $TPST volume 2.4 m

User Image Mergerbrief Posted - 3 months ago

$SILK $BSX - HSR Possibly Expires Midnight MergerBrief.com

User Image epsguid Posted - 3 months ago

$SILK reported a loss of $0.42, consensus was ($0.38) via @eWhispers #epsmiss http://eps.sh/d/silk

User Image Stock_Titan Posted - 3 months ago

$SILK Silk Road Medical Reports Second Quarter 2024 Financial Results https://www.stocktitan.net/news/SILK/silk-road-medical-reports-second-quarter-2024-financial-69lg1hy3xein.html

User Image NVDAMillionaire Posted - 07/31/24

$SILK Silk Road Medical, Inc. (NASDAQ:SILK): Pioneering Transcarotid Artery Revascularization as the New Standard of Care http://beyondspx.com/2024/07/29/silk-road-medical-inc-nasdaqsilk-pioneering-transcarotid-artery-revascularization-as-the-new-standard-of-care/

User Image Stock_Titan Posted - 07/24/24

$BSX $SILK Boston Scientific Announces Results for Second Quarter 2024 https://www.stocktitan.net/news/BSX/boston-scientific-announces-results-for-second-quarter-lv0ok72dojkd.html

User Image TheSleeeve Posted - 4 months ago

$AVTE Just gonna hold this one for awhile. Another $NKTX and $SILK and $vtyx More diamonds perhaps ....gold...another boat maybe. I don't even know anymore. Congrats longs.

User Image IN0V8 Posted - 4 months ago

$SILK Stifel cuts to hold from buy Stifel raises target price to $27.50 from $23

User Image erevnon Posted - 4 months ago

Stifel downgrades Silk Road Medical $SILK from Buy to Hold and raises the price target from $23 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image DonCorleone77 Posted - 4 months ago

$SILK Silk Road Medical downgraded to Hold from Buy at Stifel Stifel downgraded Silk Road Medical (SILK) to Hold from Buy with a price target of $27.50, up from $23, after the company entered into a definitive acquisition agreement with Boston Scientific (BSX). The acquisition is expected to close the second half of 2024 and the new target price reflects the agreed upon purchase price, the analyst tells investors in a research note.

User Image intratio Posted - 4 months ago

$SILK Silk Road Medical Inc Our engine assessed that the value of this equity has a rather grim outlook for the immediate future and has a dramatic negative long-term outlook

User Image DonCorleone77 Posted - 4 months ago

$SILK Silk Road Medical downgraded to Sell from Buy at Argus Argus downgraded Silk Road Medical (SILK) to Sell from Buy, reflecting the company's planned acquisition by Boston Scientific (BSX). Under the terms of the deal announced on June 18, Boston will pay $27.50 per Silk share and the firm recommends selling the shares, the analyst tells investors.

User Image intratio Posted - 4 months ago

$SILK https://www.intratio.com/stock-forecast/SILK Silk Road Medical Inc Our statistical model deduces that this stock s value has a very negative short-term outlook and is anticipated to lose heights in the next 90 days

User Image intratio Posted - 4 months ago

https://www.intratio.com/stock-forecast/SILK The mathematical model foresees that the stock price of this company will immediately drop precipitously and will continue to trend quite negatively in the next months $SILK

User Image insiderbuyingselling Posted - 4 months ago

$SILK new insider selling: 66 shares. http://insiderbuyingselling.com/?t=SILK

User Image intratio Posted - 4 months ago

Silk Road Medical Inc The trained A.I assessed that the stock price of this company clearly has a bad short-term setup and is facing massive downsides in the longer term $SILK

User Image intratio Posted - 4 months ago

https://www.intratio.com/stock-forecast/SILK Our mathematical model estimates that this stock s price will soon begin to trend sharply downward and will suffer a highly negative trend that will persist $SILK

User Image intratio Posted - 4 months ago

https://www.intratio.com/stock-forecast/SILK The artificial intelligence is forecasting this company s stock price will decrease during the next few days and is anticipated to lose heights in the next 90 days $SILK

User Image intratio Posted - 4 months ago

$SILK https://www.intratio.com/stock-forecast/SILK Our trained A.I. deduces that this company s value will have a sharp negative trend in the short-term and projects a dramatically gloomy future

User Image intratio Posted - 4 months ago

https://www.intratio.com/stock-forecast/SILK Silk Road Medical Inc Our predictive algorithm is forecasting this equity s value will instantly and significantly lessen and will continue to have a very poor trend over the next months $SILK

User Image wohlfruchter Posted - 06/26/24

$SILK our attorneys are investigating the fairness of the proposed sale of Silk Road Medical to Boston Scientific; the sales price of $27.50 per share in cash is below the price target for SILK of $32.00 per share set by David Toung of Argus Research on June 14, 2024, and below SILK’s 52-week high of $33.78 per share; read more at: https://wohlfruchter.com/cases/silk-road-medical/

User Image intratio Posted - 06/25/24

https://www.intratio.com/stock-forecast/SILK Silk Road Medical Inc The trained model foretells that this stock s price will shortly drop and, in the long run, faces severe disadvantages $SILK

User Image intratio Posted - 06/24/24

https://www.intratio.com/stock-forecast/SILK Silk Road Medical Inc The algorithm computed this stock s price will fall sharply in the short-term and has really poor long-term fundamentals $SILK

User Image intratio Posted - 5 months ago

The predictive algorithm is making the inference that this company s stock price will immediately drop precipitously and will continue to trend quite negatively in the next months $SILK

Analyst Ratings
Stifel Hold Jul 17, 24
Argus Research Sell Jul 11, 24
Lake Street Hold Jun 18, 24
JP Morgan Neutral May 1, 24
Piper Sandler Neutral May 1, 24
Argus Research Buy Mar 7, 24
Stifel Buy Feb 29, 24
JP Morgan Neutral Feb 29, 24
Piper Sandler Neutral Feb 29, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Jones Marie L. CAO and VP, Finance CAO and VP, Finance Oct 27 Sell 6.607 656 4,334 54,941 10/30/23
Buchanan Lucas W. COO/CFO COO/CFO Oct 04 Sell 15.223 2,662 40,524 435,848 10/06/23
Rogers Erica J. President and CEO President and CEO Mar 02 Sell 56.6189 1,651 93,478 267,988 09/29/23
Klemz Kevin M EVP/Chief Legal Offi.. EVP/Chief Legal Officer/Sec. Aug 17 Sell 20.105 1,539 30,942 38,797 08/18/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer May 19 Sell 22.13 6,587 145,770 109,534 08/04/23
Buchanan Lucas W. COO/CFO COO/CFO May 19 Option 10.8 9,643 104,144 215,725 07/31/23
Jones Marie L. CAO and VP, Finance CAO and VP, Finance May 19 Option 6.11 2,000 12,220 48,002 07/21/23
Rogers Erica J. President and CEO President and CEO Jul 11 Sell 31.56 1,000 31,560 269,639 07/13/23
Rogers Erica J. President and CEO President and CEO Jul 11 Option 1.6 1,000 1,600 270,639 07/13/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Jul 06 Sell 30.787 69 2,124 115,614 07/10/23
Rogers Erica J. President and CEO President and CEO May 19 Sell 32.13 1,000 32,130 269,639 06/13/23
Rogers Erica J. President and CEO President and CEO May 19 Option 1.6 1,000 1,600 270,639 06/13/23
Rogers Erica J. President and CEO President and CEO May 11 Sell 35.51 3,000 106,530 269,132 05/12/23
Rogers Erica J. President and CEO President and CEO May 11 Option 1.6 3,000 4,800 272,132 05/12/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer May 01 Sell 44.51 6,753 300,576 115,683 05/03/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer May 01 Option 8.89 6,753 60,034 122,436 05/03/23
WEATHERMAN ELIZABETH H Director Director Apr 17 Sell 41.91 5,000 209,550 144,454 04/19/23
Rogers Erica J. President and CEO President and CEO Apr 11 Sell 39.77 6,000 238,620 269,132 04/12/23
Rogers Erica J. President and CEO President and CEO Apr 11 Option 1.6 6,000 9,600 275,132 04/12/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Apr 03 Sell 39.42 6,753 266,203 115,683 04/05/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Apr 03 Option 5.19 6,753 35,048 122,436 04/05/23
WEATHERMAN ELIZABETH H Director Director Mar 15 Sell 41.91 5,000 209,550 149,454 03/17/23
Rogers Erica J. President and CEO President and CEO Mar 13 Sell 42.23 6,000 253,380 269,132 03/15/23
Rogers Erica J. President and CEO President and CEO Mar 13 Option 1.6 6,000 9,600 275,132 03/15/23
Ruedy Richard EVPClin&Reg.Affa.. EVPClin&Reg.Affairs&QA Mar 02 Sell 47.73 2,373 113,263 145,483 03/06/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Mar 02 Sell 47.74 3,868 184,658 115,683 03/06/23
Buchanan Lucas W. COO/CFO COO/CFO Mar 02 Sell 47.11 9,918 467,237 205,575 03/06/23
Rogers Erica J. President and CEO President and CEO Mar 02 Sell 47.1 18,043 849,825 269,132 03/06/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Mar 01 Sell 48.02 6,753 324,279 98,205 03/02/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Mar 01 Option 4.73 6,753 31,942 99,019 03/02/23
WEATHERMAN ELIZABETH H Director Director Feb 15 Sell 49.86 5,000 249,300 154,454 02/17/23
Rogers Erica J. President and CEO President and CEO Feb 13 Sell 50.94 6,000 305,640 246,199 02/15/23
Rogers Erica J. President and CEO President and CEO Feb 13 Option 1.6 6,000 9,600 252,199 02/15/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Feb 01 Sell 54.05 6,753 365,000 98,205 02/03/23
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Feb 01 Option 4.73 6,753 31,942 104,958 02/03/23
Chou Tony M. Director Director Feb 01 Sell 55 13,008 715,440 75,707 02/03/23
Buchanan Lucas W. COO/CFO COO/CFO Jan 17 Sell 53.72 86,244 4,633,028 188,811 01/19/23
Buchanan Lucas W. COO/CFO COO/CFO Jan 17 Option 7.73 83,528 645,671 217,289 01/19/23
WEATHERMAN ELIZABETH H Director Director Jan 17 Sell 54.693 56,355 3,082,224 159,454 01/19/23
Chou Tony M. Director Director Jan 12 Sell 55 1,006 55,330 87,709 01/17/23
Rogers Erica J. President and CEO President and CEO Jan 11 Sell 51.53 6,000 309,180 246,199 01/13/23
Rogers Erica J. President and CEO President and CEO Jan 11 Option 1.6 6,000 9,600 252,199 01/13/23
Buchanan Lucas W. COO/CFO COO/CFO Dec 13 Option 1.6 40,000 64,000 191,527 12/15/22
Buchanan Lucas W. COO/CFO COO/CFO Dec 13 Sell 55 25,000 1,375,000 176,527 12/15/22
Chou Tony M. Director Director Dec 13 Sell 55 10,060 553,300 88,715 12/15/22
Rogers Erica J. President and CEO President and CEO Dec 12 Option 1.6 10,000 16,000 256,199 12/14/22
Rogers Erica J. President and CEO President and CEO Dec 12 Sell 53.85 10,000 538,500 246,199 12/14/22
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Nov 01 Option 1.46 6,753 9,859 104,958 11/01/22
Davis Andrew S. Chief Commercial Off.. Chief Commercial Officer Nov 01 Sell 44.17 6,753 298,280 98,205 11/01/22
Rogers Erica J. President and CEO President and CEO Sep 12 Option 1.6 10,000 16,000 256,199 09/14/22